Neurologic Manifestations of Xeroderma Pigmentosum Follow-up

1. Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis. 2011 Nov 1. 6:70. [QxMD MEDLINE Link]. [Full Text].

2. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol. 1987 Feb. 123(2):241-50. [QxMD MEDLINE Link].

3. Bradford PT, Goldstein AM, Tamura D, Khan SG, Ueda T, Boyle J, et al. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet. 2011 Mar. 48(3):168-76. [QxMD MEDLINE Link]. [Full Text].

4. Feltes BC, Bonatto D. Overview of xeroderma pigmentosum proteins architecture, mutations and post-translational modifications. Mutat Res Rev Mutat Res. 2015 Jan-Mar. 763:306-320. [QxMD MEDLINE Link].

5. Lehmann J, Seebode C, Martens MC, Emmert S. Xeroderma Pigmentosum - Facts and Perspectives. Anticancer Res. 2018 Feb. 38 (2):1159-1164. [QxMD MEDLINE Link]. [Full Text].

6. Tamura D, DiGiovanna JJ, Khan SG, Kraemer KH. Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients. Photodermatol Photoimmunol Photomed. 2014 Apr-Jun. 30(2-3):146-52. [QxMD MEDLINE Link].

7. Lim R, Sethi M, Morley AMS. Ophthalmic Manifestations of Xeroderma Pigmentosum: A Perspective from the United Kingdom. Ophthalmology. 2017 Nov. 124 (11):1652-1661. [QxMD MEDLINE Link].

8. Mimaki T, Itoh N, Abe J, et al. Neurological manifestations in xeroderma pigmentosum. Ann Neurol. 1986 Jul. 20(1):70-5. [QxMD MEDLINE Link].

9. Anttinen A, Koulu L, Nikoskelainen E, Portin R, Kurki T, Erkinjuntti M, et al. Neurological symptoms and natural course of xeroderma pigmentosum. Brain. 2008 Aug. 131:1979-89. [QxMD MEDLINE Link].

10. Natale V, Raquer H. Xeroderma pigmentosum-Cockayne syndrome complex. Orphanet J Rare Dis. 2017 Apr 4. 12 (1):65. [QxMD MEDLINE Link]. [Full Text].

11. Fekete R. Xeroderma pigmentosum/de sanctis-cacchione syndrome: unusual cause of ataxia. Case Rep Neurol. 2014 Jan. 6(1):83-7. [QxMD MEDLINE Link]. [Full Text].

12. Jaspers NG, Raams A, Silengo MC, Wijgers N, Niedernhofer LJ, Robinson AR, et al. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet. 2007 Mar. 80(3):457-66. [QxMD MEDLINE Link].

13. Larson DM, Cunningham BB. Photodynamic Therapy in a Teenage Girl with Xeroderma Pigmentosum Type C. Pediatr Dermatol. 2012 Jan 26. [QxMD MEDLINE Link].

14. Ettinger M, Berneburg M. [Light protection for xeroderma pigmentosum]. Hautarzt. 2017 May. 68 (5):359-363. [QxMD MEDLINE Link].

15. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature. 1968 May 18. 218(5142):652-6. [QxMD MEDLINE Link].

16. De Sanctinis C, Cacchione A. L'idiozia xerodermica. Riv Sepr Freniatr. 1932. 56:269-292.

17. Hakamada S, Watanabe K, Sobue G, et al. Xeroderma pigmentosum: neurological, neurophysiological and morphological studies. Eur Neurol. 1982. 21(2):69-76. [QxMD MEDLINE Link].

18. Hayashi M, Araki S, Kohyama J, et al. Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Dev. 2005 Jan. 27(1):34-8. [QxMD MEDLINE Link].

19. Johnson RT, Squires S. The XPD complementation group. Insights into xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy. Mutat Res. 1992 Mar. 273(2):97-118. [QxMD MEDLINE Link].

20. Kohyama J, Furushima W, Sugawara Y, et al. Convulsive episodes in patients with group A xeroderma pigmentosum. Acta Neurol Scand. 2005 Oct. 112(4):265-9. [QxMD MEDLINE Link].

21. Lehmann AR. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie. 2003 Nov. 85(11):1101-11. [QxMD MEDLINE Link].

22. Mimaki T, Tagawa T, Tanaka J, et al. EEG and CT abnormalities in xeroderma pigmentosum. Acta Neurol Scand. 1989 Aug. 80(2):136-41. [QxMD MEDLINE Link].

23. Moriwaki S, Nishigori C, Imamura S, et al. A case of xeroderma pigmentosum complementation group F with neurological abnormalities. Br J Dermatol. 1993 Jan. 128(1):91-4. [QxMD MEDLINE Link].

24. Nance MA, Berry SA. Cockayne syndrome: review of 140 cases. Am J Med Genet. 1992 Jan 1. 42(1):68-84. [QxMD MEDLINE Link].

25. Rapin I, Weidenheim K, Lindenbaum Y, et al. Cockayne syndrome in adults: review with clinical and pathologic study of a new case. J Child Neurol. 2006 Nov. 21(11):991-1006. [QxMD MEDLINE Link].

26. Robbins JH, Brumback RA, Mendiones M, et al. Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form. Brain. 1991 Jun. 114 ( Pt 3):1335-61. [QxMD MEDLINE Link].

27. Robbins JH, Brumback RA, Moshell AN. Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: evidence for a neurodegeneration in later life caused by defective DNA repair. Eur Neurol. 1993. 33(3):188-90. [QxMD MEDLINE Link].

28. Robbins JH, Kraemer KH, Lutzner MA, et al. Xeroderma pigmentosum. An inherited diseases with sun sensitivity, multiple cutaneous neoplasms, and abnormal DNA repair. Ann Intern Med. 1974 Feb. 80(2):221-48. [QxMD MEDLINE Link].

29. Roytta M, Anttinen A. Xeroderma pigmentosum with neurological abnormalities. A clinical and neuropathological study. Acta Neurol Scand. 1986 Feb. 73(2):191-9. [QxMD MEDLINE Link].

30. Weeda G, Ma LB, van Ham RC, et al. Structure and expression of the human XPBC/ERCC-3 gene involved in DNA repair disorders xeroderma pigmentosum and Cockayne's syndrome. Nucleic Acids Res. 1991 Nov 25. 19(22):6301-8. [QxMD MEDLINE Link].

31. Weeda G, van Ham RC, Vermeulen W, et al. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell. 1990 Aug 24. 62(4):777-91. [QxMD MEDLINE Link].

Peter Hedera, MD, PhD Associate Professor, Department of Neurology, Vanderbilt University School of Medicine

Peter Hedera, MD, PhD is a member of the following medical societies: American Academy of Neurology, American College of Medical Genetics and Genomics, American Neurological Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Kenneth J Mack, MD, PhD Senior Associate Consultant, Department of Child and Adolescent Neurology, Mayo Clinic

Kenneth J Mack, MD, PhD is a member of the following medical societies: American Academy of Neurology, Child Neurology Society, Phi Beta Kappa, Society for Neuroscience

Disclosure: Nothing to disclose.

Amy Kao, MD Attending Neurologist, Children's National Medical Center

Amy Kao, MD is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, Child Neurology Society

Disclosure: Have stock (managed by a financial services company) in healthcare companies including Allergan, Cellectar Biosciences, CVS Health, Danaher Corp, Johnson & Johnson.

Robert Stanley Rust, Jr, MD, MA Former Thomas E Worrell Jr Professor of Epileptology and Neurology, Co-Director of FE Dreifuss Child Neurology and Epilepsy Clinics, Director, Child Neurology, University of Virginia School of Medicine; Chair-Elect, Child Neurology Section, American Academy of Neurology

Robert Stanley Rust, Jr, MD, MA is a member of the following medical societies: American Academy of Neurology, American Epilepsy Society, American Headache Society, American Neurological Association, Child Neurology Society, International Child Neurology Association, Society for Pediatric Research

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article